consistently, previous studies have shown that FABP5 promotes ferroptosis sensitivity in cancer and neuronal models [6]
Consequently, improving amylin-based medicines focuses on enabling longer action, resulting in weekly use, possibly even oral use and, most importantly, combining the functions of more than one hormone known for being involved in glucose control and the promotion of satiety
Most published studies involve: Rodents Cell cultures Laboratory models High-quality randomized human clinical trials remain scarce
According to recent studies, GLP-1-based drugs may also be beneficial for not only obesity and diabetes but also cardiovascular disease, sleep apnea, and kidney disease
Elderly patients might have decreased clearance and be more prone to nausea or dehydration, so timing should consider frailty and functional status
One case study indicates that activated charcoal may help treat diarrhea, but higher quality studies are necessary (25)
